Rapidly growing mycobacterial infections: Spectrum of diseases, antimicrobial susceptibility, pathology and treatment outcomes

Journal of the Medical Association of Thailand

Volumn 86, Issue 8, 2003, Pages 772-780

  Sungkanuparph, Somnuek ^a   Sathapatayavongs, Boonmee ^a   Pracharktam, Roongnapa ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Lymphadenitis; Mycobacterium abscessus; Mycobacterium chelonae; Mycobacterium fortuitum; Outcome; Pathology; Rapidly Growing Mycobacteria; Susceptibility; Sweet's Syndrome

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; CEFAZOLIN; CEFOXITIN; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; FOSFOMYCIN; FUSIDIC ACID; GENTAMICIN; IMIPENEM; LINCOMYCIN; MACROLIDE; NETILMICIN; OFLOXACIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TEICOPLANIN; TETRACYCLINE; TOBRAMYCIN; VANCOMYCIN;

ABSCESS DRAINAGE; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; CHRONIC OTITIS MEDIA; CLINICAL ARTICLE; CLINICAL FEATURE; EYE INFECTION; FEMALE; HUMAN; LUNG INFECTION; LYMPHADENITIS; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM CHELONEI; MYCOBACTERIUM FORTUITUM; NONHUMAN; SKIN ABSCESS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; DRAINAGE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM INFECTIONS, ATYPICAL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0141813424     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Wallace RJ Jr, Swenson JM, Silcox VA, et al. Spectrum of diseases due to rapidly growing mycobacteria. Rev Infect Dis 1983; 5: 657-79.
2. Drabick JJ, Duffy PE, Samlaska CP, et al. Disseminated Mycobacterium chelonae subspecies chelonae infection with cutaneous and osseous manifestations. Arch Dermatol 1990; 126: 1064-7.
3. Wallace RJ Jr, Brown BA, Onyi GO. Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: Importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis 1992; 166: 405-12.
4. Fonseca E, Alzate C, Canedo T, Contreras F. Nodudar lesions in disseminated Mycobacterium fortuitum infection. Arch Dermatol 1987; 123: 1603-4.
5. Wright JE. Non-tuberculous mycobacterial lymphadenitis. Aust N Z J Surg 1996; 66: 225-8.
6. Pesce RR, Fejka S, Colodny SM. Mycobacterium fortuitum presenting as an asymptomatic enlarging pulmonary nodule. Am J Med 1991; 91: 310-2.
7. Rolston KVI, Jones PG, Fainstein V, Bodey GP. Pulmonary disease caused by rapidly growing mycobacteria in patients with cancer. Chest 1985; 87: 503-6.
8. Kesten S, Chaparro C. Mycobacterial Infections in lung transplant recipients. Chest 1999; 115: 741-5.
9. Gran JT, Eng J, Refvem OK, et al. Monoarthritis due to Mycobacterium chelonae. J Rheumatol 1987; 14: 852-3.
10. Ford JG, Huang AJW, Pflugfelder SC, et al. Nontuberculous mycobacterial keratitis in South Florida. Ophthalmology 1998; 105: 1652-8.
11. Huang SCM, Soong HK, Chang JS, Liang YS. Non, tuberculous mycobacterial keratitis: A study of 22 cases. Br J Ophthalmol 1996; 80: 962-8.
12. Matoba A. Mycobacterium chelonae keratitis. Am J Ophthalmol 1987; 103: 595-6.
13. Ambler JS, Meisler DM, Zakov ZN, et al. Endogenous Mycobacterium chelonae endophthalmitis. Am J Ophthalmol 1989; 108: 338-9.
14. Lowry PW, Jarvis WR, Oberle AD, et al. Mycobacterium chelonae causing otitis media in an ear-nose-and throat practice. N Engl J Med 1988; 319: 978-82.
15. Austin WK, Lockey MW. Mycobacterium fortuitum mastoiditis. Arch Otolaryngol 1976; 102: 558-60.
16. Raad II, Vartivarian S, Khan A, and Bodey GP. Catheter-related infections caused by the Mycobacterium fortuitum complex: 15 cases and review. Rev Infect Dis 1991; 13: 1120-5.
17. Hoy JF, Rolston KVI, Hopper RL, Bodey GP. Mycobacterium fortuitum bacteremia in patients with cancer and long-term venous catheter. Am J Med 1987; 83: 213-7.
18. Clegg HW, Foster MT, Sanders WE Jr, Baine WB. Infection due to organisms of Mycobacterium fortuitum complex after augmentation mammoplasty: Clinical and epidemiologic features. J Infect Dis 1983; 147: 427-33.
19. Montoliu J, Gatell JM, Ponal J, et al. Disemminated visceral infection with Mycobacterium fortuitum in a hemodialysis patient. Am J Nephrol 1985; 5: 205-11.
20. Ingram CW, Tanner DC, Durack DT, Kemodle GW Jr, Corey GR. Disseminated infection with rapidly growing mycobacteria. Clin Infect Dis 1993; 16: 463-71.
21. Wallace RJ Jr, O'Brien R, Glassroth J, Raleigh J, Dutt A. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am Rev Respir Dis 1990; 142: 940-53.
22. Heifets LB, Jenkins PA. Speciation of Mycobacteria in Clinical Laboratories. In: Gangadharam PRJ, Jenkins PA, eds. Mycobacteria I Basic Aspects. New York: Chapman & Hall; 1998: 308-51.
23. Cynamon MH, Klemens SP. Drug Susceptibility tests for Mycobacterium fortuitum and Mycobacterium chelonae. In: Heifets LB, ed. Drug Susceptibility in the Chemotherapy of Mycobacterial Infections. Florida: CRC Press, Inc; 1991: 147-60.
24. Woods GL, Washington JA II. Mycobacteria other than Mycobacterium tuberculosis: Review of microbiologic and clinical aspects. Rev Infect Dis 1987; 9: 275-94.
25. Choonhakarn C, Chetchotisakd P, Jirarattanapochai K, Mootsikapun P. Sweet's syndrome associated with non-tuberculous mycobacterial infection: A report of five cases. Br J Dermatol 1998; 139: 107-10.
26. Chetchotisakd P, Mootsikapun P, Anunnatsiri S, et al. Disseminated infection due to rapidly growing mycobacteria in immunocompetent hosts presenting with chronic lymphadenopathy: A previously unrecognized clinical entity. Clin Infect Dis 2000; 30: 29-34.
27. Franklin DJ, Starke JR, Brady MT, Brown BA, Wallace RJ Jr. Chronic otitis media after tympanostomy tube placement caused by Mycobacterium abscessus: A new clinical entity? Am J Otol 1994; 15: 313-20.
28. Robin JB, Beatty BF, Dunn S, et al. Mycobacterium chelonei keratitis after radical keratotomy. Am J Ophthalmol 1986; 102: 72-3.
29. Roussel TJ, Stern WH, Goodman DF, Whitcher JP. Post-operative mycobacterial endophthalmitis. Am J Ophthalmol 1989; 107: 403-6.
30. Swenson JM, Wallace RJ Jr, Silcox VA, Thornsberry C. Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob Agents Chemother 1985; 28: 807-11.
31. Young LS, Berlin OGW, Inderlied CB. Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria. Am J Med 1987; 82: 23-6.
32. Wallace RJ Jr, Brown BA, Onyi GO. Susceptibilities of Mycobacterium fortuitum biovar fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid. Antimicrob Agents Chemother 1991; 35: 773-5.
33. Wallace RJ Jr, Bedsole G, Sumter G, et al. Activities of ciprofloxacin and ofloxacin against rapidly growing mycobacteria with demonstration of acquired resistance following single-drug therapy. Antimicrob Agents Chemother 1990; 34: 65-70.
34. Brown BA, Wallace RJ Jr, Onyi GO, DeRosas V, Wallace RJ III. Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae and M. chelonae -like organisms. Antimicrob Agents Chemother 1992; 36: 180-4.
35. Dalovisio JR, Pankey GA. In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to amikacin. J Infect Dis 1978; 137: 318-21.
36. Chittasobhaktra T, Vibhagool A, Prachaktam R. Clinical manifestation and drug susceptibility of rapidly growing mycobacteria. J Infect Dis Antimicrob Agents 1999; 16: 109-14.
37. Wallace RJ Jr, Tanner D, Brennan PJ, Brown BA. Clinical trial of clarithromycin for cutaneous (disseminated) infectioon due to Mycobacterium chelonae. Ann Intern Med 1993; 119: 482-6.
38. Tebas P, Sultan F, Wallace RJ Jr, Fraser V. Rapid development of resistance to clariyhromycin following monotherapy for disseminated infection in a heart transplant patient. Clin Infect Dis 1995; 20: 443-4.